Author

Nieves Perdigones

Translational Genomics Research InstituteORCID 0000-0002-3736-6933Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:whole-exome sequencing· 2 Research Focus:benchmarking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Muhammed MurtazaiD· 2 shared Ahuva Odenheimer-Bergman· 1 shared Alexandra Nazareno· 1 shared Ann E. McCulloughiD· 1 shared Barbara A. PockajiD· 1 shared Bhavika PateliD· 1 shared Bradon R. McDonaldiD· 1 shared Brenda J. ErnstiD· 1 shared

Activity by Year

2019-2019 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenomics

Muhammed MurtazaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

GenomicsScience Translational MedicinePeer-reviewedAug 7, 2019

Detection of residual disease after neoadjuvant therapy in breast cancer using personalized circulating tumor DNA analysis

Bradon R. McDonald, Tania Contente‐Cuomo, Stephen‐John Sammut…·Muhammed Murtaza

A personalized ctDNA test achieves high accuracy for residual disease detection after neoadjuvant therapy in breast cancer.

306 citationstop 1%

humanDNA methylation

𝕏 PostBluesky

Cancer BiologybioRxivPreprintFeb 25, 2019

Identification of frequent activating HER2 mutations in primary canine pulmonary adenocarcinoma

Gwendolen Lorch, Karthigayini Sivaprakasam, Victoria Zismann…·William P. D. Hendricks

This study identifies HER2 mutations in canine pulmonary adenocarcinomas, finding V659E mutations in 38% of cases and their association with drug sensitivity.

DOI 10.1101/528182

whole-exome sequencingexperimental assay

𝕏 PostBluesky